These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17784818)

  • 21. Mechanism of the immune response to human factor VIII in murine hemophilia A.
    Wu H; Reding M; Qian J; Okita DK; Parker E; Lollar P; Hoyer LW; Conti-Fine BM
    Thromb Haemost; 2001 Jan; 85(1):125-33. PubMed ID: 11204564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
    Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
    Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of intermediate-purity factor VIII (FVIII) concentrate on lymphocyte proliferation and apoptosis: transforming growth factor-beta is a significant immunomodulatory component of FVIII.
    Hodge G; Han P
    Br J Haematol; 2001 Nov; 115(2):376-81. PubMed ID: 11703339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of factor VIII-specific unresponsiveness by intrathymic factor VIII injection in murine hemophilia A.
    Madoiwa S; Yamauchi T; Kobayashi E; Hakamata Y; Dokai M; Makino N; Kashiwakura Y; Ishiwata A; Ohmori T; Mimuro J; Sakata Y
    J Thromb Haemost; 2009 May; 7(5):811-24. PubMed ID: 19220731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemophilia A Inhibitor Subjects Show Unique PBMC Gene Expression Profiles That Include Up-Regulated Innate Immune Modulators.
    Karim AF; Soltis AR; Sukumar G; Königs C; Ewing NP; Dalgard CL; Wilkerson MD; Pratt KP
    Front Immunol; 2020; 11():1219. PubMed ID: 32595650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution of Th1- and Th2-induced anti-factor VIII IgG subclasses in congenital and acquired hemophilia patients.
    Reding MT; Lei S; Lei H; Green D; Gill J; Conti-Fine BM
    Thromb Haemost; 2002 Oct; 88(4):568-75. PubMed ID: 12362225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of human factor VIII inhibitors in rats by immunization with human recombinant factor VIII: a small animal model for humans with high responder inhibitor phenotype.
    Jarvis MA; Levin LG; Harrison JA; DePianto DJ; Suzuki CM; Ziaja CL; Brown JE; Jolly KW; Reisner HM; Abildgaard CF; Powell JS
    Thromb Haemost; 1996 Feb; 75(2):318-25. PubMed ID: 8815584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.
    Zou J; Rudwaleit M; Brandt J; Thiel A; Braun J; Sieper J
    Arthritis Rheum; 2003 Mar; 48(3):780-90. PubMed ID: 12632433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations in T-lymphocyte sub-set profiles and cytokine secretion by PBMC of systemic lupus erythematosus patients upon in vitro exposure to organochlorine pesticides.
    Dar SA; Das S; Ramachandran VG; Bhattacharya SN; Mustafa MD; Banerjee BD; Verma P
    J Immunotoxicol; 2012; 9(1):85-95. PubMed ID: 22214240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokine secretion pattern in treatment of lymphocytes of multiple sclerosis patients with fumaric acid esters.
    Zoghi S; Amirghofran Z; Nikseresht A; Ashjazadeh N; Kamali-Sarvestani E; Rezaei N
    Immunol Invest; 2011; 40(6):581-96. PubMed ID: 21510778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombin generation as objective parameter of treatment response in patients with severe haemophilia A and high-titre inhibitors.
    Luna-Záizar H; Beltrán-Miranda CP; Esparza-Flores MA; Soto-Padilla J; Bergés-García A; Rodríguez-Zepeda MD; Pompa-Garza MT; Jaloma-Cruz AR
    Haemophilia; 2014 Jan; 20(1):e7-14. PubMed ID: 24354488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro cytokine synthesis in unstimulated and mitogen-stimulated peripheral blood mononuclear cells from individuals with schizophrenia.
    Kozłowska E; Żelechowska P; Wysokiński A; Rasmus P; Łucka A; Brzezińska-Błaszczyk E
    J Investig Med; 2019 Oct; 67(7):1053-1060. PubMed ID: 31053623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant and plasma-derived factor VIII products induce distinct splenic cytokine microenvironments in hemophilia A mice.
    Qadura M; Waters B; Burnett E; Chegeni R; Bradshaw S; Hough C; Othman M; Lillicrap D
    Blood; 2009 Jul; 114(4):871-80. PubMed ID: 19411636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII.
    Matino D; Gargaro M; Santagostino E; Di Minno MN; Castaman G; Morfini M; Rocino A; Mancuso ME; Di Minno G; Coppola A; Talesa VN; Volpi C; Vacca C; Orabona C; Iannitti R; Mazzucconi MG; Santoro C; Tosti A; Chiappalupi S; Sorci G; Tagariello G; Belvini D; Radossi P; Landolfi R; Fuchs D; Boon L; Pirro M; Marchesini E; Grohmann U; Puccetti P; Iorio A; Fallarino F
    J Clin Invest; 2015 Oct; 125(10):3766-81. PubMed ID: 26426076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolution of in vitro cow's milk protein-specific inflammatory and regulatory cytokine responses in preterm infants with necrotising enterocolitis.
    Abdelhamid AE; Chuang SL; Hayes P; Fell JM
    J Pediatr Gastroenterol Nutr; 2013 Jan; 56(1):5-11. PubMed ID: 22903007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenovirus-mediated factor VIII gene expression results in attenuated anti-factor VIII-specific immunity in hemophilia A mice compared with factor VIII protein infusion.
    Bristol JA; Gallo-Penn A; Andrews J; Idamakanti N; Kaleko M; Connelly S
    Hum Gene Ther; 2001 Sep; 12(13):1651-61. PubMed ID: 11535168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of immune tolerance by neonatal intravenous injection of human factor VIII in murine hemophilia A.
    Madoiwa S; Yamauchi T; Hakamata Y; Kobayashi E; Arai M; Sugo T; Mimuro J; Sakata Y
    J Thromb Haemost; 2004 May; 2(5):754-62. PubMed ID: 15099282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Higher frequency of CD4(+)CD25(high) Treg cells in hemophilia patients with factor VIII inhibitor.
    Ding KY; Ji WC; Wu JS; Li T; Sheng YY
    Genet Mol Res; 2014 Mar; 13(1):1774-81. PubMed ID: 24668665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term anti-FVIII antibody response in Bethesda-negative haemophilia A patients receiving continuous replacement therapy.
    Klintman J; Hillarp A; Berntorp E; Astermark J
    Br J Haematol; 2013 Nov; 163(3):385-92. PubMed ID: 24032553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitor antibody development and T cell response to human factor VIII in murine hemophilia A.
    Qian J; Borovok M; Bi L; Kazazian HH; Hoyer LW
    Thromb Haemost; 1999 Feb; 81(2):240-4. PubMed ID: 10063999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.